Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 5,823,922 9.600% | 963,782 (+19.83%) | Filing History |
| 2024-01-17 4:54 pm Purchase | 2024-01-10 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (US) LLC | 3,451,825 5.700% | 3,451,825 (New Position) | Filing History |
| 2023-10-10 4:52 pm Purchase | 2023-09-28 | 13G | Sutro Biopharma, Inc. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,549,320 5.860% | 3,549,320 (New Position) | Filing History |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 0 0.000% | -2,708,975 (Position Closed) | Filing History |
| 2023-02-14 11:45 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,347,946 5.800% | 187,530 (+5.93%) | Filing History |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,565,099 9.700% | 3,091,304 (+124.96%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 3,211,872 5.590% | 3,211,872 (New Position) | Filing History |
| 2023-02-07 2:55 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 4,860,140 8.500% | 1,160,097 (+31.35%) | Filing History |
| 2023-02-01 1:09 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 2,838,135 4.900% | -429,812 (-13.15%) | Filing History |
| 2023-01-23 4:31 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (Asia) Pte. Ltd. | 1,369,021 2.400% | -1,053,652 (-43.49%) | Filing History |
| 2022-07-08 4:19 pm Purchase | 2022-07-01 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (Asia) Pte. Ltd. | 2,422,673 5.200% | 2,422,673 (New Position) | Filing History |
| 2022-02-14 12:00 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 2,708,975 5.900% | 338,000 (+14.26%) | Filing History |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,473,795 5.400% | 65,400 (+2.72%) | Filing History |
| 2022-02-04 1:45 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 3,267,947 7.100% | 3,267,947 (New Position) | Filing History |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 3,700,043 8.000% | 982,114 (+36.13%) | Filing History |
| 2022-01-18 5:18 pm Purchase | 2022-01-07 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.800% | 1,306,254 (+70.45%) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,408,395 5.200% | 2,408,395 (New Position) | Filing History |
| 2021-04-05 5:28 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BRISTOL MYERS SQUIBB CO BMY | 1,726,197 3.800% | 1,726,197 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Citadel Advisors LLC | 1,301,804 2.900% | -427,172 (-24.71%) | Filing History |
| 2021-02-16 4:22 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 1,144,979 2.500% | -869,708 (-43.17%) | Filing History |